Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers

Description

The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.

Conditions

Infant of Diabetic Mother

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.

Maternal Probiotic Supplementation for Improved Neurodevelopmental Outcomes in Infants of Diabetic Mothers (IDMs)

Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers

Condition
Infant of Diabetic Mother
Intervention / Treatment

-

Contacts and Locations

Minneapolis

University of Minnesota, Minneapolis, Minnesota, United States, 55455

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pregnant people in their second or third trimester with a diagnosis of gestational diabetes.
  • * BMI 18.5-45 kg/m2 at first prenatal visit
  • * Age 21-45 at time of delivery
  • * Report social support for and intention to exclusively breastfeed for at least 3 months
  • * Singleton pregnancy
  • * Alcohol consumption \>1 drink per week during pregnancy/lactation
  • * Tobacco consumption during pregnancy/lactation
  • * Inability to speak/understand English
  • * Known congenital metabolic, endocrine disease (other than GDM), or congenital illness affecting infant feeding
  • * History of type I Diabetes
  • * Birthing parent currently taking over the counter probiotic preparation

Ages Eligible for Study

21 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Minnesota,

Study Record Dates

2025-08-31